Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 114

Results For "risk"

1504 News Found

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
Healthcare | May 04, 2022

New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months


India’s Drugs Controller General green lights trial of TRIA heart valve
News | May 04, 2022

India’s Drugs Controller General green lights trial of TRIA heart valve

The procedures have been performed by Dr. Kaushal Pandey at P.D. Hinduja Hospital in Mumbai, India


Kokilaben Dhirubhai Ambani Hospital launches third da Vinci robotic surgical system
Hospitals | May 04, 2022

Kokilaben Dhirubhai Ambani Hospital launches third da Vinci robotic surgical system

It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer


Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day
Medical Device | May 04, 2022

Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day

This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene


Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools
Biotech | May 02, 2022

Physicians foresee an Alzheimer's Disease treatment revolution supported by advanced testing tools

Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education


Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Biotech | April 29, 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo


Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance
Digitisation | April 28, 2022

Airtel, Apollo Hospitals, and Cisco join forces for 5G connected ambulance

When a critical patient is en-route to the hospital and every second makes a difference, the 5G Connected ambulance acts as an extension of the emergency room


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation


USFDA approves first Covid-19 treatment for young children
Drug Approval | April 26, 2022

USFDA approves first Covid-19 treatment for young children

This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age